Related Experiment Videos

Naltrexone modulates growth in infant rats

Life Sciences
|December 12, 1983
PubMed

Insights

Naltrexone, an opiate antagonist, impacts rat growth differently based on dosage. High doses stimulate growth, while low doses inhibit it, suggesting endorphins

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Opiate antagonists like naltrexone are known to block opioid receptors.
  • Endogenous opioids and their receptors play roles in various physiological processes.
  • The impact of opiate antagonists on somatic growth during development is not fully understood.

Purpose of the Study:

  • To investigate the dose-dependent effects of naltrexone on somatic growth in preweaning rats.
  • To explore the potential role of endorphins and opiate receptors in developmental processes.

Main Methods:

  • Administration of naltrexone at two different doses (50 mg/kg and 1 mg/kg) to preweaning rats.
  • Assessment of somatic growth parameters, including body weight and organ weights.
  • Evaluation of physical development and maturation of spontaneous motor activity.

Main Results:

  • High-dose naltrexone (50 mg/kg) significantly increased body weight, organ weights, and accelerated physical maturation and motor activity.
  • Low-dose naltrexone (1 mg/kg) exhibited opposite effects, inhibiting growth and development.
  • The duration of morphine-induced analgesia blockade correlated with the observed growth effects.

Conclusions:

  • Naltrexone demonstrates dose-dependent modulatory effects on somatic growth in developing rats.
  • These findings suggest a significant role for the endogenous opioid system in regulating developmental events.
  • Opiate receptor activity is implicated in the control of growth and maturation during early life.

Related Concept Videos